RA CAPITAL MANAGEMENT, L.P.

Holdings History for iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

Symbol: ITOS
Investment type: Equity / Common stock, par value $0.001 per share
Latest Disclosed Shares Owned: 2,134,806 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in iTeos Therapeutics, Inc. Common stock, par value $0.001 per share (ITOS)

19 May 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,134,806 shares of iTeos Therapeutics, Inc. Common stock, par value $0.001 per share (ITOS). This represents 4.9% ownership of the company. In their previous filing dated 14 May 2025, RA CAPITAL MANAGEMENT, L.P. had reported owning 4,163,276 shares, indicating a decrease of +49%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	4.9%	-50%	$15,690,824	2,134,806	-2,028,470	-49%	$7.35	13D/A	15 May 2025	19 May 2025, 17:46
RA Capital Management, L.P.	9.9%		$30,600,079	4,163,276			$7.35	13D/A	12 May 2025	14 May 2025, 18:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.36%	$0	0	-3,649,057	-100%	$10.15	Q2 2025
31 Mar 2025	0.36%	+0.16%	$21,784,870	3,649,057	+1,556,798		$5.97	Q1 2025
31 Dec 2024	0.21%	-0.11%	$16,068,549	2,092,259	-1,092,452	-34%	$7.68	Q4 2024
30 Sep 2024	0.37%	-0.04%	$32,515,899	3,184,711	-332,548	-9.5%	$10.21	Q3 2024
30 Jun 2024	0.69%	-0.17%	$52,196,124	3,517,259	-900,000	-20%	$14.84	Q2 2024
31 Mar 2024	0.77%	0%	$60,251,413	4,417,259	0		$13.64	Q1 2024
31 Dec 2023	0.76%	0%	$48,368,986	4,417,259	0		$10.95	Q4 2023
30 Sep 2023	0.95%	0%	$48,368,986	4,417,259	0		$10.95	Q3 2023
30 Jun 2023	1.1%	0%	$58,484,509	4,417,259	0		$13.24	Q2 2023
31 Mar 2023	1.4%	0%	$60,118,895	4,417,259	0		$13.61	Q1 2023
31 Dec 2022	1.7%	0%	$86,269,068	4,417,259	0		$19.53	Q4 2022
30 Sep 2022	1.8%	0%	$84,149,000	4,417,259	0		$19.05	Q3 2022
30 Jun 2022	2.4%	0%	$90,996,000	4,417,259	0		$20.60	Q2 2022
31 Mar 2022	3.1%	0%	$142,147,000	4,417,259	0		$32.18	Q1 2022
31 Dec 2021	3.6%	0%	$205,668,000	4,417,259	0		$46.56	Q4 2021
30 Sep 2021	1.7%	0%	$119,266,000	4,417,259	0		$27.00	Q3 2021
30 Jun 2021	1.8%	0%	$113,303,000	4,417,259	+1	+0%	$25.65	Q2 2021
31 Mar 2021	2.3%	0%	$150,982,000	4,417,258	0		$34.18	Q1 2021
31 Dec 2020	2.1%	0%	$149,392,000	4,417,258	0		$33.82	Q4 2020
30 Sep 2020	2%	+2%	$108,974,000	4,417,258	+4,417,258	NEW	$24.67	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.